Type 1 diabetes: open trials in China

• NCT07784725

  A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  Trial Treatment · Phase 3 · AstraZeneca

  Beijing · Cangzhou · Changchun · Changsha · Chengdu · Danyang · Ganzhou · Guiyang · Hengshui · Huizhou · Lanzhou · Panjin · Qiqihar · Shanghai · Suzhou · Xiamen · Xianyang · Zigong

  Registry updated 2026-10-30

• NCT06256614

  Washed Microbiota Transplantation for Type 1 Diabetes Mellitus

  Research · The Second Hospital of Nanjing Medical University

  Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing

  Registry updated 2026-10-26

• NCT07088068

  A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  Trial Treatment · Phase 3 · Sanofi

  Beijing · Beijing · Beijing · Changchun · Changsha · Chengdu · Chengdu · Guangzhou · Guangzhou · Hangzhou · Hangzhou · Hangzhou · Harbin · Hohhot · Jinan · Lanzhou · Luoyang · Nanchang · Nanchang · Nanjing · Nanjing · Nanjing · Pingxiang · Shanghai · Shanghai · Shenyang · Shenzhen · Tianjin · Wuhan · Wuhan · Wuxi · Yueyang · Zhengzhou · Zhenjiang

  Registry updated 2026-10-13

• NCT07845955

  JAK1 Inhibitor Ivarmacitinib for Improving Pancreatic Islet Function in T1D

  Trial Treatment · Phase 2 · Huijie Zhang

  Zhongshan Hospital,Fudan University, Shanghai

  Registry updated 2026-09-29

• NCT07776509

  A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  Trial Treatment · Phase 3 · AstraZeneca

  Beijing · Changchun · Chengdu · Guangzhou · Huzhou · Nanjing · Ningbo

  Registry updated 2026-09-25

• NCT07835724

  Environmental Determinants of Type 1 Diabetes Risk

  Research · Second Xiangya Hospital of Central South University

  the Second Xiangya Hospital, central south of university, Changsha

  Registry updated 2026-09-23

• NCT06273631

  Effect of Different Carbohydrate Intake Patterns on Glycemic Control in Patients With Type 1 Diabetes

  Trial Treatment · Yang Tao

  First Affiliated Hospital, Nanjing Medical University, Nanjing

  Registry updated 2026-09-10

• NCT07803809

  Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity

  Trial Treatment · Phase 1 · Shanghai Minwei Biotechnology Co., Ltd

  The First Affiliated Hospital of Yunnan University of Chinese Medicine (Yunnan Provincial Hospital of Traditional Chinese Medicine), Kunming

  Registry updated 2026-09-08

• NCT07797335

  AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  Chinese Academy of Medical Sciences Fuwai Hospital-Endocrinology, Beijing · Peking University People's Hospital-Endocrinology, Beijing · Cangzhou People's Hospital-Endocrinology, Cangzhou · The First Bethune hospital of Jilin University-Endocrinology, Changchun · The First People's Hospital of Changde City-Endocrinology, Changde · Changzhou No.2 People's Hospital-Endocrinology, Changzhou · The First People's Hospital of Changzhou-Endocrinology, Changzhou · Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital; Affiliated Hospital of UESTC-Endocrinology, Chengdu · Chongqing University Three Gorges Hospital-Endocrinology, Chongqing · The Second Affiliated Hospital of Chongqing Medical University-Endocrinology, Chongqing · The Second Hospital of Anhui Medical University-Endocrinology, Hefei · The Second People's Hospital of Hefei-Endocrinology, Hefei · Huzhou Central Hospital-Endocrinology, Huzhou · The Second Norman Bethune Hospital of Jilin University-Endocrinology, Jilin City · Jinan Central Hospital-General Medicine, Jinan · Huaihe Hospital of Henan University-Endocrinology, Kaifeng · Hebei PetroChina Central Hospital-Endocrinology, Langfang · Luoyang First People's Hospital-Endocrinology, Luoyang · The First Affiliated Hospital of Henan University of Science and Technology-Endocrinology, Luoyang · Nanjing First Hospital-Endocriniology, Nanjing · Nanjing Jiangning Hospital-Endocrinology, Nanjing · The Second Affiliated Hospital of Nanjing Medical University-Endocrinology, Nanjing · The First Affiliated Hospital of Nanyang Medical College-Endocrinology, Nanyang · Panjin Liaoyou Gemflower Hospital-Endocrinology, Panjin · Central Hospital of Minhang District, Shanghai-Endocrinology, Shanghai · The Second People's Hospital of Shenzhen-Endocrinology, Shenzhen · The First Hospital of Hebei Medical University-Endocrinology, Shijiazhuang · The Second Hospital of Hebei Medical University-Endocrinology, Shijiazhuang · Shiyan Taihe Hospital (Affiliated Hospital of Hubei University of Medicine)-Endocrinology, Shiyan · The Second Affiliated Hospital of Soochow University-Endocrinology, Suzhou · Qinghai Provincial People's Hospital-Endocrinology, Xining · The First Affiliated Hospital of Zhengzhou University-Endocrinology, Zhengzhou · The Second Affiliated Hospital of Zhengzhou University-Endocrinology, Zhengzhou · The Affiliated Hospital of Jiangsu University-Endocrinology, Zhenjiang

  Registry updated 2026-09-01

• NCT07503028

  An Exploratory Clinical Study Evaluating Allogeneic iPSC-derived Pancreatic Islet Cells (CRG-002) for the Treatment of Diabetic Patients With Hypoglycemia Unawareness or Severe Hypoglycemic Events

  Trial Treatment · Early phase 1 · Celregen Therapeutics

  The First Affiliated Hospital of Anhui Medicaluniversity, Hefei

  Registry updated 2026-08-26

• NCT07745244

  Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System

  Trial Treatment · SiBionics, Co, Ltd

  Zibo Central hospital, Zibo

  Registry updated 2026-08-04

• NCT07732777

  AI-Assisted Remote Insulin Pump Optimization in T1DM

  Trial Treatment · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

  Department of Endocrinology, Nanjing

  Registry updated 2026-07-29

• NCT07548996

  Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes

  Trial Treatment · Phase 2/3 · Nanjing Medical University

  Jiangsu Provincial Hospital, Nanjing

  Registry updated 2026-07-21

• NCT07621445

  Genetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter Nested Case-control Study

  Research · Second Xiangya Hospital of Central South University

  Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, Changsha

  Registry updated 2026-06-02

• NCT05498974

  China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

  Research · Second Xiangya Hospital of Central South University

  The Second Xiangya Hospital, Central South University, Changsha · Heji Hospital Affiliated to Changzhi Medical College, Changzhi · Hainan General Hospital, Haikou · Zhejiang Provincial People's Hospital, Hangzhou · The First Affiliated Hospital of Harbin Medical University, Harbin · The First People's Hospital of Yunnan, Kunming · Gansu Provincial People's Hospital, Lanzhou · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · The First Affiliated Hospital of Nanjing Medical University, Nanjing · Shenzhen Second People's Hospital, Shenzhen · The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

  Registry updated 2026-04-28

• NCT07528105

  Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes

  Trial Treatment · Early phase 1 · Shanghai Zhongshan Hospital

  Zhongshan Hospital,Fudan University, Shanghai

  Registry updated 2026-04-14

• NCT03835312

  Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM

  Trial Treatment · Children's Hospital of Fudan University

  Children's Hospital Of Fudan University, Shanghai

  Registry updated 2026-03-17

• NCT06198725

  Intervention for Children With Type 1 Diabetes Targeting Gut Microbes

  Trial Treatment · Children's Hospital of Fudan University

  Children's Hospital Of Fudan University, Shanghai

  Registry updated 2026-03-17

• NCT07468474

  Establishment of Screening Pathway for High-Risk Population of Type 1 Diabetes

  Research · Peking University First Hospital

  Peking University First Hospital, Beijing

  Registry updated 2026-03-12

• NCT07258394

  Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus

  Trial Treatment · Phase 3 · Nanjing Medical University

  Deparement of Endocrinology and Metabolism, The First Affiliated Hospital with Nanjing Medical University, Nanjing

  Registry updated 2026-03-05

• NCT04187443

  MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema

  Trial Treatment · Phase 1 · Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.

  The Second Xiangya Hospital of Central South University, Changsha · West China Hospital of Sichuan University, Chengdu · Shanghai General Hospital, Shanghai

  Registry updated 2025-09-29

• NCT06731218

  Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus

  Trial Treatment · Phase 1 · Hangzhou Reprogenix Bioscience, Inc

  Tianjin First Center Hospital, Tianjin

  Registry updated 2025-09-15

• NCT07144696

  Study on the Improvement of Metabolic Indicators in Type 1 Diabetes Patients

  Trial Treatment · Peking University First Hospital

  Peking University First Hospital, Beijing

  Registry updated 2025-09-04

• NCT07097818

  Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2

  Trial Treatment · Second Xiangya Hospital of Central South University

  Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing · Institute of Metabolism and Endocrinology, Second Xiangya Hospital of Centra South University, Changsha · Department of Endocrinology and Metabolism, Laboratory of Diabetes and metabolism research, West China Hospital, Sichuan University, Chengdu · Department of Endocrinology, Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou · Endocrinology and Metabolism Center, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang · Department of Endocrinology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou · Department of Endocrinology and Metabolism, Institute of Endocrinology, The First Affiliated Hospital of China Medical University, Shenyang · Department of Endocrinology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen · Second Department of Endocrinology and Metabolism, Tangshan Gongren Hospital, Tangshan · Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan

  Registry updated 2025-09-03

• NCT07126873

  A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes

  Trial Treatment · Phase 1/2 · EndoCell Therapeutics, Inc.

  Shanghai Changzheng Hospital, Shanghai

  Registry updated 2025-08-22

All Type 1 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error